Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling [J. Biophotonics 9, No. 11-12, 1344-1354 (2016)]

Rozhin Penjweini; Michele M Kim; Baochang Liu; Timothy C Zhu

doi:10.1002/jbio.201700016

Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling [J. Biophotonics 9, No. 11-12, 1344-1354 (2016)]

J Biophotonics. 2017 Mar;10(3):473-474. doi: 10.1002/jbio.201700016. Epub 2017 Feb 6.

Authors

Rozhin Penjweini¹, Michele M Kim¹, Baochang Liu¹, Timothy C Zhu¹

Affiliation

¹ University of Pennsylvania, School of Medicine, Department of Radiation Oncology, 3400 Civic Center Boulevard TRC 4W, Philadelphia, Pennsylvania, 19104, USA.

Abstract

In the article by R. Penjweini, M. M. Kim et al. (doi: 10.1002/jbio.201600121), published in J. Biophotonics 9, 1344-1354 (2016), the constants C₀₁ , C₀₂ , b₁ , and b₂ determined from fitting the fluorescence single value decomposition (SVD) for phantoms with different optical properties and the corresponding Figure 2(a) are not correct. This erratum is published to correct the Section 2.3 and Figure 2(a).

Keywords: HPPH-mediated PDT; PDT dose; cure index; fluence; in vivo mice study; mean [1O2]rx; photobleaching ratio.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding